knowledge -WSS

knowledge

author：focus 2025-09-04 22:17:14 - browse：8836

A liver with a smooth and healthy left half and a bumpy, browning right half — chronic disease coverage from STAT — Adobe

Akero Therapeutics said Monday that extending treatment with its experimental drug for the liver disease known as MASH from six months to two years resulted in better outcomes for patients — most notably reductions in liver scarring at a rate three times higher than placebo without worsening other symptoms.

The mid-stage study of the Akero drug called efruxifermin achieved its main goal in September 2022. With longer treatment, more patients with MASH responded to the drug, while those who initially benefited showed durable improvements.

“We’re really pleased with the data. It’s exactly what we were hoping to see,” said Kitty Yale, Akero’s chief development officer, in an interview with STAT. “It’s not just the high response rates, but the fact that responses are sustained and broadened as well.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Peter Hotez and the public health issue of online harassment
Next article： Stem cell clinics for heart failure: buyer be wary

WSS

HIV vaccine remains elusive. Immunologists keep trying new ideas

Microsoft's Peter Lee says ChatGPT shouldn't be used for initial diagnosis

'Ancient DNA,' 23andMe reveal African American ancestries

Dramatically reducing cancer deaths requires the PASTEUR Act

My superpower is killing ticks

Attacks on the drug industry will lead to fewer breakthroughs

knowledge

knowledge

leisure time

Anesthesiologist group: stop taking Ozempic before surgery

Who is Magistrate Judge Moxila Upadhyaya in Trump's Jan. 6 case?

In age of alternative facts, a scholarly course on calling out crap

Solving academic medical centers' existential crisis

Dobbs anniversary: the lost opportunity of abortion as health care

Treeline, Josh Bilenker's next biotech, is cloaked in mystery

How one medical school became remarkably diverse

Nearly two

What does generative AI mean for health care? We asked experts

Who is Magistrate Judge Moxila Upadhyaya in Trump's Jan. 6 case?

hotspot

White House drug shortage group privately met with industry

'Ancient DNA,' 23andMe reveal African American ancestries

My superpower is killing ticks

Data integrity in scientific journals requires "effort" by publishers, institutions

Military medical care influenced by rank and race, new study finds

Humana, CVS hope to turn members into patients at clinics

hotspot

focus

focus

Wikipedia